KRMD Long Put Strategy
KRMD (KORU Medical Systems, Inc.), in the Healthcare sector, (Medical - Instruments & Supplies industry), listed on NASDAQ.
KORU Medical Systems, Inc. is dedicated to the development, manufacturing, and commercialization of mobile medical devices, primarily serving the ambulatory infusion market across both the United States and international territories. The company's primary offerings revolve around mechanical infusion solutions, notably their FREEDOM infusion systems. These comprehensive systems encompass components such as the FREEDOM60 and FreedomEdge syringe drivers, alongside specialized HIgH-Flo subcutaneous safety needle sets and precision flow rate tubing. Beyond their product range, KORU Medical also supplies educational content and training materials to healthcare professionals, patients, and patient advocates. The distribution of their products is managed through a combination of direct sales efforts, partnerships with medical device distributors, and online channels. Established in 1980, the firm's corporate headquarters are situated in Chester, New York.
KRMD (KORU Medical Systems, Inc.) trades in the Healthcare sector, specifically Medical - Instruments & Supplies, with a market capitalization of approximately $151.6M, a beta of 0.41 versus the broader market, a 52-week range of 3.21-6.608, average daily share volume of 153K, a public-listing history dating back to 1994, approximately 73 full-time employees. These structural characteristics shape how KRMD stock options price implied volatility around earnings windows, capital events, and macro-driven sector rotations.
A beta of 0.41 indicates KRMD has historically moved less than the broader market, dampening realized volatility and producing tighter expected-move bands per unit of dollar exposure.
What is a long put on KRMD?
A long put buys downside exposure with a fixed maximum loss equal to the premium paid; profit accrues if the underlying closes below the strike minus premium at expiration.
KRMD snapshot
As of August 14, 2026, spot at $3.38, ATM IV 25.40%, IV rank 1.99%, expected move 7.28%. The long put on KRMD below is built from the end-of-day chain, with strikes snapped to listed contracts and premiums pulled from the bid/ask midpoint at a 35-day expiry.
Why this long put structure on KRMD specifically: KRMD IV at 25.40% is on the cheap side of its 1-year range, which favors premium-buying structures like a KRMD long put, with a market-implied 1-standard-deviation move of approximately 7.28% (roughly $0.25 on the underlying). The 35-day window matched to the front-month expiry keeps theta exposure bounded while still capturing the post-snapshot move; longer-dated KRMD expiries trade a higher absolute premium for lower per-day decay. Position sizing on KRMD should anchor to the underlying notional of $3.38 per share and to the trader's directional view on KRMD stock.
KRMD long put setup
The KRMD long put below is built from the end-of-day chain, with each option leg priced at the bid/ask midpoint of its listed strike. With KRMD at $3.38 on that close, the first option leg uses a $3.38 strike; additional legs (when the strategy has them) anchor to spot-relative offsets. Premiums come from the bid/ask midpoint on the listed KRMD chain at a 35-day expiry; the cross-strike IV skew is reflected directly in the per-leg values rather than approximated. Quantity sizing assumes one contract per option leg (or 100 KRMD shares for the stock leg in covered calls and collars).
| Action | Type | Strike / Basis | Premium (est) |
|---|---|---|---|
| Buy 1 | Put | $3.38 | N/A |
KRMD long put risk and reward
- Net Premium / Debit
- N/A
- Max Profit (per contract)
- Unbounded
- Max Loss (per contract)
- Unbounded
- Breakeven(s)
- None on modeled curve
- Risk / Reward Ratio
- N/A
Max profit equals the strike minus premium times 100 (reached at zero); max loss equals the premium times 100. Breakeven is strike minus premium.
KRMD long put payoff curve
Modeled P&L at expiration across a range of underlying prices for the long put on KRMD. Each row is one sampled price point from the computed payoff curve; the full curve uses 200 price points internally before being summarized into 10 rows here.
When traders use long put on KRMD
Long puts on KRMD hedge an existing long KRMD stock position or express a bearish view with defined risk; position sizing typically scales the put notional to the underlying KRMD exposure being hedged.
KRMD thesis for this long put
The market-implied 1-standard-deviation range for KRMD extends from approximately $3.13 on the downside to $3.63 on the upside. A KRMD long put expresses a directional view that the underlying closes below the strike minus premium at expiration, frequently sized to hedge an existing long KRMD position with one put per 100 shares held. Current KRMD IV rank near 1.99% sits in the lower third of its 1-year distribution, where IV often re-expands toward the mean; this favors premium-buying structures and disadvantages premium-selling structures on KRMD at 25.40%. As a Healthcare name, KRMD options can move on sector-level news flow (peer earnings, regulatory updates, industry-specific macro data) in addition to KRMD-specific events.
KRMD long put positions are structurally bearish; the modeled P&L assumes European-style exercise at expiration and ignores early assignment, transaction costs, dividends paid before expiry on the stock leg (when present), and the bid-ask spread on the listed chain. KRMD positions also carry Healthcare sector concentration risk; news flow inside the sector (peer earnings, regulatory shifts, supply-chain headlines) can move KRMD alongside the broader basket even when KRMD-specific fundamentals are unchanged. Long-premium structures like a long put on KRMD are particularly exposed to IV-crush risk through scheduled events (earnings, FDA decisions, central-bank meetings) where IV typically contracts post-event regardless of the directional outcome. Always rebuild the position from current KRMD chain quotes before placing a trade.
Frequently asked questions
- What is a long put on KRMD?
- A long put on KRMD is the long put strategy applied to KRMD (stock). The strategy is structurally bearish: A long put buys downside exposure with a fixed maximum loss equal to the premium paid; profit accrues if the underlying closes below the strike minus premium at expiration. With KRMD stock at $3.38 on the most recent close, the strikes shown on this page are snapped to the nearest listed KRMD chain strike and the premiums come straight from that session's bid/ask midpoint.
- How are KRMD long put max profit and max loss calculated?
- Max profit equals the strike minus premium times 100 (reached at zero); max loss equals the premium times 100. Breakeven is strike minus premium. For the KRMD long put priced from the end-of-day chain at a 30-day expiry (ATM IV 25.40%), the computed maximum profit is unbounded per contract and the computed maximum loss is unbounded per contract. Live intraday quotes will differ as the chain moves through the trading session.
- What is the breakeven for a KRMD long put?
- The breakeven for the KRMD long put priced on this page is no defined breakeven on the modeled curve at expiration, derived from the end-of-day chain's premiums. Breakeven is the underlying price at which the strategy's P&L crosses zero ignoring transaction costs and assignment risk. The KRMD market-implied 1-standard-deviation expected move in the same options snapshot is approximately 7.28%; if the move sits well outside the breakeven distance, the structure's risk-reward becomes correspondingly tighter.
- When should you consider a long put on KRMD?
- Long puts on KRMD hedge an existing long KRMD stock position or express a bearish view with defined risk; position sizing typically scales the put notional to the underlying KRMD exposure being hedged.
- How does current KRMD implied volatility affect this long put?
- KRMD ATM IV is at 25.40% with IV rank near 1.99%, which is on the low end of its 1-year range. Premium-buying structures (long call, long put, debit spreads) are relatively cheap in this regime; premium-selling structures collect less credit per unit risk.